As of 2023, Tuberculosis treatment coverage in Italy stood at approximately 74%. Based on the forecast data, coverage shows a gradual decline, decreasing to 73% in 2024, 72% in 2025, and 71% by 2026 and 2027, with a further drop to 70% in 2028. This represents a year-on-year decline of about 1% in 2024 and 2025, stabilizing somewhat in subsequent years. The compound annual growth rate (CAGR) over this forecast period indicates a consistent decrease in treatment coverage.

Future trends to watch for include:

Efforts by healthcare authorities to reverse the coverage decline through improved health policies and patient outreach.
Impact of new therapeutic interventions and technological advancements on treatment effectiveness and accessibility.
Potential shifts in healthcare funding and resource allocation driven by emerging public health priorities.